A Review On Memory, Alzheimer's Disease Pathophysiology, Treatment, And Animal Models

Memory is vital to experiences and related to limbic systems, it is the retention of information over time for the purpose of influencing future action. Memory is the ability to take in information, store it, and recall it at a later time. Information can be viewed as passing through several storage "buffers" of differing capacity and duration. Alzheimer’s disease acknowledged as progressive multifarious neurodegenerative disorder, is the leading cause of dementia in late adult life. Pathologically it is characterized by intracellular neurofibrillary tangles and extracellular amyloidal protein deposits contributing to senile plaques. Over the last two decades, advances in the field of pathogenesis have inspired the researchers for the investigation of novel pharmacological therapeutics centered more toward the pathophysiological events of the disease. Currently available treatments i.e. acetylcholinesterase inhibitors (rivastigmine, galantamine, donepezil) and N-methyl D-aspartate receptor antagonist (memantine) contribute minimal impact on the disease and target late aspects of the disease. These drugs decelerate the progression of the disease, provide symptomatic relief but fail to achieve a definite cure.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-22
DOI
https://doi.org/10.5281/zenodo.13824815
Primary Topic
Phosphodiesterase function and regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review On Memory, Alzheimer's Disease Pathophysiology, Treatment, And Animal Models

Zenodo (CERN European Organization for Nuclear Research)
Phosphodiesterase function and regulation
article

A Review On Memory, Alzheimer's Disease Pathophysiology, Treatment, And Animal Models

article en

Abstract

Memory is vital to experiences and related to limbic systems, it is the retention of information over time for the purpose of influencing future action. Memory is the ability to take in information, store it, and recall it at a later time. Information can be viewed as passing through several storage "buffers" of differing capacity and duration. Alzheimer’s disease acknowledged as progressive multifarious neurodegenerative disorder, is the leading cause of dementia in late adult life. Pathologically it is characterized by intracellular neurofibrillary tangles and extracellular amyloidal protein deposits contributing to senile plaques. Over the last two decades, advances in the field of pathogenesis have inspired the researchers for the investigation of novel pharmacological therapeutics centered more toward the pathophysiological events of the disease. Currently available treatments i.e. acetylcholinesterase inhibitors (rivastigmine, galantamine, donepezil) and N-methyl D-aspartate receptor antagonist (memantine) contribute minimal impact on the disease and target late aspects of the disease. These drugs decelerate the progression of the disease, provide symptomatic relief but fail to achieve a definite cure.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 64%
Phosphodiesterase function and regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.